Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Hee-Jeong Choi, Eulji University Hospital
ClinicalTrials.gov Identifier:
NCT00460057
First received: April 12, 2007
Last updated: August 2, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2007
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)